IInVitria Optimizes Hybridoma Cell Culture with new product - ZapHybridoma
–InVitria’s launch of Zap‐Hybridoma provides a powerful solution for hybridoma cell culture. Zap‐Hybridoma was created to improve monoclonal antibody productivity and deliver easier purification of the target product., Mar 2 2010
|
CSU Researchers' Discovery Could Help Prevent Dementia
CSU researchers have discovered low levels of two chemicals in the brain cause the brain to shrink - a condition that leads to dementia - and the discovery could help scientists prevent the condition., Nov 2 2009
|
Bioscience Boost Training for Bioscience and FDA Regulated Industries
Take a look at a new profession. If you enjoy working with your hands, if the bioscience world intrigues you, the Bioscience Boost Training program will introduce you to this exciting industry., Sep 30 2009
|
SpectraDigital Announces HIV/AIDS Initiative with a Brazilian partner
SpectraDigital Corporation of Canada announced the publication in the September issue of Nature Biotechnology of an article summarizing a partnership model with FK Biotec of Porto Alegre, Brazil, to undertake a joint AIDS/HIV project., Sep 29 2009
|
Zila agrees to be acquired by Tolmar
Fort Collins-based pharmaceutical firm Tolmar entered into a definitive agreement to purchase Zila, based in Scottsdale, Ariz., on June 25. , Sep 21 2009
|
Recent publication by R. K. Lantz in Journal of Dairy Science
Effect of milking frequency and dosing interval on the pharmacokinetics of cephapirin after intramammary infusion in lactating dairy cows, Sep 21 2009
|
Recent publication by R. K. Lantz in Journal of Veterinary Pharmacology
Effect of milk fraction on concentrations of cephapirin and desacetylcephapirin in bovine milk after intramammary infusion of cephapirin sodium, Sep 21 2009
|
Inviragen Receives Additional Grant to Support Dengue Vaccine Development
Inviragen has received a $600,000 grant from the National Institute of Allergy and, Sep 10 2009
|
Propel Labs and Chata Biosystems Enter into Partnership for Instrumentation Development and Sales Distribution in Asia Pacific.
Propel Labs, LLC. and Chata Biosystems, Inc. have entered into a strategic partnership which includes instrumentation development and distribution of Chata products in Asia Pacific. As part of this partnership Propel Labs will assist in developing the next generations of Chata’s award winning Chem+Mix™ instrumentation for increased automation and efficiency in the laboratory., Sep 10 2009
|